Shots:

• NovellusDx will provide its functional genomics assay FACT (Functional Annotation for Cancer Treatment) to Primetech- for pre-clinical market with sales- marketing and research/technical support in Japan exclusively
• FACT has capability to determine trial outcomes in patients- now this system will help in developing anti-cancer drugs and mechanism of action
•  Japan is the first territory where NovellusDx will be marketing as agent agreement

        Ref: Primetech | Image:  Business wire